ApoE of the HepG2 Cell Surface Includes a Major Pool Associated with Chondroitin Sulfate Proteoglycans
Abstract
We have investigated the association of apolipoprotein E (apoE) with the HepG2 cell surface (i.e. plasma membrane and extracellular matrix) using domain specific monoclonal antibodies against apoE. Growth in beta-D-xyloside decreased the incorporation of 35S into glycosaminoglycans by 31% and cell surface apoE by 45% with a concomitant increase in apoE secretion (4.3-fold), underlining the importance of glycosaminoglycan association of apoE. Heparinase (3-10 U/mL) or heparin (1 mg/mL) decreased apoE by 25 and 30.5%, respectively, which suggests that some apoE is associated with cell surface heparan sulfate proteoglycans. Chondroitinase ABC (1.5 U/mL) reduced cell surface apoE by 40%, indicating that a major pool of apoE is associated with chondroitin sulfate proteoglycans. Further enzymatic and displacement analysis suggested that cell surface apoE associates specifically with GAGs containing chondroitin-4-sulfates. 3H1, a monoclonal antibody that recognizes an epitope within the lipid-binding C-terminal domain of apoE, decreased binding of apoE to chondroitin sulfate proteoglycans in solid-phase assays by 77% and to heparan sulfate proteoglycans by 46%, suggesting that this region is of increased importance for binding to chondroitin sulfate proteoglycans. Previous studies with 3H1 demonstrated that apoE of the extracellular matrix is lipid-poor (Burgess, J. W., Gould, D. R., and Marcel, Y. L. (1998) J. Biol. Chem. 273, 5645-5654), but we show here that apoE on the remaining cell surface is lipid-associated. In summary, lipidated apoE associates with the HepG2 plasma membrane through interactions with chondroitin-4-sulfate containing GAGs and, to a lesser extent, HSPG.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The binding of apoE to cell-surface glycosaminoglycans (GAG) such as chondroitin sulfate (CS) and dermatan sulfate (DS) proteoglycans plays an important role in lipoprotein catabolism.
“Besides the apoE-HSPG interaction, the binding of apoE to cell-surface glycosaminoglycans (GAG) such as chondroitin sulfate (CS) and dermatan sulfate (DS) proteoglycans has been demonstrated to play an important role in lipoprotein catabolism.”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [13]
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,990 · see citing works
Glycosaminoglycans and Their Binding to Biological Macromolecules
Lindahl, U., & Höök, M. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.002125 · Cited by 835 · see citing works
Aviezer, D., Levy, E., Safran, M., Svahn, C. M., Buddecke, E., Schmidt, A., David, G., Vlodavsky, I., & Yayon, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42321-0 · Cited by 255 · see citing works
Eichner, J. E., Kuller, L. H., Orchard, T. J., Grandits, G. A., McCallum, L. M., Ferrell, R. E., & Neaton, J. D. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90732-r · Cited by 247 · see citing works
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.
Weisgraber, K. H., Rall, S. C., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35898-2 · Cited by 240 · see citing works
Self-citationThe low-density lipoprotein receptor-related protein: double agent or decoy?
Brown, M. S., Herz, J., Kowal, R. C., & Goldstein, J. L. (1991) · Current Opinion in Lipidology · doi:10.1097/00041433-199104000-00002 · Cited by 178 · see citing works
Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor
Habuchi, H., Suzuki, S., Saito, T., Tamura, T., Harada, T., Yoshida, K., & Kimata, K. (1992) · Biochemical Journal · doi:10.1042/bj2850805 · Cited by 173 · see citing works
Kuipers, F., Jong, M. C., Lin, Y., Eck, M. V., Havinga, R., Bloks, V. W., Verkade, H. J., Hofker, M. H., Moshage, H. J., van Berkel, T. J. C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119841 · Cited by 167 · see citing works
Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections
Hamilton, R., Wong, J., Guo, L., Krisans, S. K., & Havel, R. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42343-0 · Cited by 152 · see citing works
Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis.
Lugemwa, F. N., & Esko, J. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89549-0 · Cited by 117 · see citing works
Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts.
Greve, H., Cully, Z., Blumberg, P., & Kresse, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37644-0 · Cited by 106 · see citing works
Linton, M. F., Hasty, A. H., Babaev, V. R., & Fazio, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2181 · Cited by 100 · see citing works
Characterization of monoclonal antibodies against human apolipoprotein E.
Milne, R. W., DOUSTE‐BLAZY, P., Marcel, Y. L., & Retegui, L. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110225 · Cited by 80 · see citing works
Self-citationHamati, H. F., Britton, E. L., & Carey, D. J. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.6.2495 · Cited by 78 · see citing works
Cell Surface Proteoglycans Modulate Net Synthesis and Secretion of Macrophage Apolipoprotein E
Lucas, M., & Mazzone, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13454 · Cited by 63 · see citing works
Shimano, H., Namba, Y., Ohsuga, J.-I., Kawamura, M., Yamamoto, K., Shimada, M., Gotoda, T., Harada, K., Yazaki, Y., & Yamada, N. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117218 · Cited by 57 · see citing works
Altered apolipoprotein E secretion in cytokine treated human astrocyte cultures
Baskin, F., Smith, G. M., Fosmire, J. A., & Rosenberg, R. N. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)05335-x · Cited by 56 · see citing works
Owensby, D. A., Morton, P. A., & Schwartz, A. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84694-x · Cited by 47 · see citing works
Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells.
Lilly-Stauderman, M., Brown, T., Balasubramaniam, A., & Harmony, J. A. K. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40746-1 · Cited by 44 · see citing works
Bützow, R. C., Fukushima, D., Twardzik, D. R., & Ruoslahti, E. I. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.3.721 · Cited by 38 · see citing works
The HepG2 Extracellular Matrix Contains Separate Heparinase- and Lipid-releasable Pools of ApoE
Burgess, J. W., Gould, D. R., & Marcel, Y. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5645 · Cited by 30 · see citing works
Self-citationZuckerman, S. H., & O’Neal, L. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.6.743 · Cited by 24 · see citing works
Post-translational processing of the inter-α-trypsin inhibitor in the human hepatoma HepG2 cell line
Héron, A., Bourguignon, J., Callé, A., Borghi, H., Sesboüé, R., Mehrpour, M., & Martin, J. P. (1994) · Biochemical Journal · doi:10.1042/bj3020573 · Cited by 23 · see citing works
Hormonal regulation of human apolipoprotein E gene expression in HepG2 cells
Ogbonna, G., Theriault, A., & Adeli, K. (1993) · International Journal of Biochemistry · doi:10.1016/0020-711x(93)90347-h · Cited by 20 · see citing works
Vandenbrouck, Y., Janvier, B., LORIETTE, C., Bereziat, G., & Andréani, M. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00463.x · Cited by 15 · see citing works
Investigation of plasma membrane-associated apolipoprotein E in primary macrophages
Deng, J., Rudick, V. L., Rudick, M. J., & Dory, L. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37435-6 · Cited by 15 · see citing works
Sjöberg, M., & FRIES, E. F. B. (1990) · Biochemical Journal · doi:10.1042/bj2720113 · Cited by 15 · see citing works
Binding of perlecan to transthyretin qin vitro
Smeland, S., Kolset, S. O., Lyon, M., Norum, K. R., & Blomhoff, R. (1997) · Biochemical Journal · doi:10.1042/bj3260829 · Cited by 14 · see citing works
Santhosh, A., Mathew, S., & Sudhakaran, P. R. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00229739 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cell surface heparan sulfate proteoglycans and lipoprotein metabolism
Kolset, S. O., & Salmivirta, M. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050031 · Cited by 75 · see citing works
Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2
Datta, G., White, C. R., Dashti, N., Chaddha, M., Palgunachari, M. N., Gupta, H., Handattu, S. P., Garber, D. W., & Anantharamaiah, G. M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.019 · Cited by 60 · see citing works
Bultel-Brienne, S., Lestavel, S., Pilon, A., Laffont-Proust, I., Tailleux, A., Fruchart, J., Siest, G., & Barthelemy-Clavey, V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201943200 · Cited by 60 · see citing works
Hepatic Catabolism of Remnant Lipoproteins: Where the Action Is
Havel, R. J., & Hamilton, R. L. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000115382.53810.24 · Cited by 58 · see citing works
Yamauchi, Y., Deguchi, N., Takagi, C., Tanaka, M., Dhanasekaran, P., Nakano, M., Handa, T., Phillips, M. C., Lund-Katz, S., & Saito, H. (2008) · Biochemistry · doi:10.1021/bi8003999 · Cited by 53 · see citing works
Swarnakar, S., Beers, J. K., Strickland, D. K., Azhar, S., & Williams, D. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101691200 · Cited by 36 · see citing works
Shuvaev, V. V., Laffont, I., & Siest, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01285-5 · Cited by 27 · see citing works
Photoaffinity Probes for the Identification of Sequence-Specific Glycosaminoglycan-Binding Proteins
Joffrin, A. M., & Hsieh‐Wilson, L. C. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c06046 · Cited by 22 · see citing works
Klezovitch, O., Formato, M., Cherchi, G. M., Weisgraber, K. H., & Scanu, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909644199 · Cited by 17 · see citing works
Evans, V. C., Foster, H., Graham, I. R., Foster, K., Athanasopoulos, T., Simons, J. P., Dickson, G., & Owen, J. S. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.169 · Cited by 15 · see citing works
Auger, A., Truong, T., Rhainds, D., Lapointe, J., Letarte, F., & Brissette, L. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02115.x · Cited by 13 · see citing works
A Biophysical Approach to the Identification of Novel ApoE Chemical Probes
Kraft, L., Serpell, L. C., & Atack, J. R. (2019) · Biomolecules · doi:10.3390/biom9020048 · Cited by 9 · see citing works
Dynamic and stable pools of apoE differ functionally at the HepG2 cell surface
Burgess, J. W., & Marcel, Y. L. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30273-x · Cited by 8 · see citing works
Self-citationApolipoprotein C-I and Apolipoprotein E Production During Adipocyte Differentiation
Nguyen, A. T. (2009) · Library, Museums and Press - UDSpace (University of Delaware)
Vectorisation d'ARN par voie orale et parentérale
Stalder, T. (2024) · theses.fr (ABES) · doi:10.70675/d509592fzbb96z4f17zb286z5040de22fd65
Heparin-Binding Proteins in the Nanoparticle Corona: An Overlooked Player at the Bio–Nano Interface
Olivieri, P. H., Justo, G. Z., Esko, J. D., & Sousa, A. A. (2026) · ACS Omega · doi:10.1021/acsomega.6c09380
- Authors
- Burgess, J. W., Liang, P., Vaidyanath, C., & Marcel, Y. L.
- Affiliations
- Ottawa Heart Institute (CA)
- Corresponding author
- Marcel, Yves L.
- ORCID
- Vaidyanath, Chantal
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1998-12-19
- Volume
- 38
- Issue
- 2
- Pages
- 524-531
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1990717706
- Cited by
- 16
- References
- 30
- Citations by year
- 2026: 1 · 2024: 1 · 2020: 1 · 2019: 1
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott Laboratories
- Eli Lilly and Company
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Keywords
- apolipoprotein E, HepG2 cells, cell surface, chondroitin sulfate proteoglycans, heparan sulfate proteoglycans, glycosaminoglycans, chondroitin 4-sulfate, lipid modification, plasma membrane, extracellular matrix, apoE secretion, heparinase, chondroitinase ABC
- MeSH terms
- Apolipoproteins E, Cell Membrane, Glycosaminoglycans, Heparin, Carcinoma, Hepatocellular, Humans, Hymecromone, Chondroitin Sulfate Proteoglycans, Sulfates, Suramin, Tumor Cells, Cultured, Protein Structure, Tertiary, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review